Triple
T6003495
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Alimta |
E133650
|
entity |
| Predicate | mayRequirePremedicationWith |
P37226
|
FINISHED |
| Object | corticosteroids |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: corticosteroids | Statement: [Alimta, mayRequirePremedicationWith, corticosteroids]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: mayRequirePremedicationWith Context triple: [Alimta, mayRequirePremedicationWith, corticosteroids]
-
A.
requiresPremedication
chosen
Indicates that one entity must receive premedication (a preparatory medical treatment) before another specified procedure, treatment, or action can occur.
-
B.
doseAdjustmentRequiredIn
Indicates that a change in the amount or frequency of a treatment or medication is necessary within a specified context, such as a condition, setting, or patient group.
-
C.
requiresMedicalClearance
Indicates that one entity must obtain formal approval from a qualified medical authority before engaging in, accessing, or proceeding with the other entity or activity.
-
D.
hasContraindication
Indicates that one entity (such as a treatment, drug, or procedure) should not be used or performed in the presence of another entity (such as a condition, factor, or co-medication) because it may cause harm or adverse effects.
-
E.
hasMaintenanceDose
Indicates that an entity is associated with a specific ongoing dose used to maintain a desired therapeutic effect after initial treatment.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c00872444c8190bfaf1739dcec765c |
completed | March 22, 2026, 3:19 p.m. |
| NER | Named-entity recognition | batch_69c04f0f63148190826198281dce3713 |
completed | March 22, 2026, 8:20 p.m. |
| PD | Predicate disambiguation | batch_69c049e3316c819087ea635fa7ee8472 |
completed | March 22, 2026, 7:58 p.m. |
Created at: March 22, 2026, 4:06 p.m.